These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3013650)

  • 21. Synthesis of 15-cis-(4-n-propylcyclohexyl)-16,17,18,19,20-pentanor-9-de oxy-6,9 alpha-nitriloprostaglandin F1 methyl ester (OP-2507), a novel anti-cerebral ischemic agent.
    Iguchi S; Miyata Y; Miyake H; Arai Y; Okegawa T; Kawasaki A
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():670-3. PubMed ID: 2526558
    [No Abstract]   [Full Text] [Related]  

  • 22. Protective effect of DM-9384, a novel pyrrolidone derivative, against experimental cerebral anoxia.
    Sakurai T; Hatanaka S; Tanaka S; Yamasaki T; Kojima H; Akashi A
    Jpn J Pharmacol; 1990 Sep; 54(1):33-43. PubMed ID: 2273646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological study of nicergoline. (I): Protective effect against anoxic brain damages in animals].
    Shintomi K; Egou H; Tanaka T; Itakura T; Yoshimoto K; Matsumoto M; Matsuoka Y
    Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):445-56. PubMed ID: 3013737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of suloctidil in the protection of the cerebral function].
    Nishi H; Kadowaki S; Endo N
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):37-46. PubMed ID: 6311699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological study of TJ-8007 (Tsumura-Zokumeito) (I): Protective effects of TJ-8007 against anoxic brain damage].
    Goto K; Suekawa M; Aburada M; Hosoya E
    Nihon Yakurigaku Zasshi; 1987 Jun; 89(6):355-63. PubMed ID: 3623336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental cerebral ischemia after bilateral common carotid artery ligation in SHRSP, SHRSR and Wistar rats: correlation between blood pressure and degree of ischemia].
    Katayama Y; Terashi A; Sugimoto S; Inamura K; Suzuki S; Sekiguchi F; Akashi A
    No To Shinkei; 1984 Nov; 36(11):1069-75. PubMed ID: 6098292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-hypoxic effect of piracetam and its interaction with prostacyclin.
    Nikolova M; Nikolov R; Milanova D
    Methods Find Exp Clin Pharmacol; 1984 Jul; 6(7):367-71. PubMed ID: 6390021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study on the anti-hypoxic effect of cinnarizine and its interaction with prostacyclin.
    Nikolov R; Nikolova M; Milanova D
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):135-8. PubMed ID: 6379343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic interactions between piracetam and dihydroergocristine in some animal models of cerebral hypoxia and ischaemia.
    Berga P; Beckett PR; Roberts DJ; Llenas J; Massingham R
    Arzneimittelforschung; 1986 Sep; 36(9):1314-20. PubMed ID: 3098253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of minaprine on the cerebrum of rodents.
    Okuyama S; Karasawa Y; Shiratsuchi A; Araki H; Aihara H
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):381-95. PubMed ID: 3175336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological studies of reiousan which contains bezoar and ginseng: III. Effects on experimental cerebral ischemia].
    Morishita S; Shoji M; Oguni Y; Sugimoto C; Hirai Y; Toma S; Ito C
    Nihon Yakurigaku Zasshi; 1991 Dec; 98(6):435-42. PubMed ID: 1783324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of a novel imidazole derivative against cerebral anoxia.
    Yasuda H; Shuto S; Tsumagari T; Nakajima A
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):136-44. PubMed ID: 686903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol.
    Palmer C; Vannucci RC; Towfighi J
    Pediatr Res; 1990 Apr; 27(4 Pt 1):332-6. PubMed ID: 2342827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of KB-2796, a new calcium antagonist, in cerebral hypoxia and ischemia.
    Hara H; Ozaki A; Yoshidomi M; Sukamoto T
    Arch Int Pharmacodyn Ther; 1990; 304():206-18. PubMed ID: 2241412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects on cerebral perfusion of prostacyclin administered directly into patients with fulminant hepatic failure and acute renal failure.
    Davenport A; Will EJ; Davison AM
    Nephron; 1991; 59(3):449-54. PubMed ID: 1758536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iptakalim protects against hypoxic brain injury through multiple pathways associated with ATP-sensitive potassium channels.
    Zhu HL; Luo WQ; Wang H
    Neuroscience; 2008 Dec; 157(4):884-94. PubMed ID: 18951957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral blood flow and edema in perinatal hypoxic-ischemic brain damage.
    Mujsce DJ; Christensen MA; Vannucci RC
    Pediatr Res; 1990 May; 27(5):450-3. PubMed ID: 2345670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of dipfluzine on experimental brain edema in rats.
    Wang YL; He RR
    Zhongguo Yao Li Xue Bao; 1994 May; 15(3):201-5. PubMed ID: 7976370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of prostacyclin treatment on the changes of cyclic nucleotide levels of rat antral and fundic gastric mucosa in different experimental ulcer models.
    Balint GA
    Jpn J Exp Med; 1989 Jun; 59(3):135-7. PubMed ID: 2554033
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of NC-1100, a calcium channel blocker, on experimental cerebral ischemia/anoxia in rodents].
    Matsumura T; Furuichi H; Izumi J; Kamatsuka Y; Takei M; Nakata N; Ito S; Suda H; Kizaki K; Kurimoto T
    Nihon Yakurigaku Zasshi; 1993 Mar; 101(3):177-86. PubMed ID: 8486322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.